DeepMed Research

Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Procedure: long-term screening

First Posted Date: 2003-04-16

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 711

Registration Number: NCT00002934

Locations: 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
CCOP - Green Bay, Green Bay, Wisconsin, United States
🇺🇸
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 27 locations

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 3

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2003-04-09

Last Posted Date: 2011-09-21

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00058149

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

and more 58 locations

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

Phase 3

Completed

Conditions: Pancreatic Cancer

Interventions: Radiation: radiation therapy
Drug: Gemcitabine

First Posted Date: 2003-04-09

Last Posted Date: 2023-07-05

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 74

Registration Number: NCT00057876

Locations: 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Mercy Hospital and Medical Center, Chicago, Illinois, United States

and more 224 locations

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Extensive Stage Small Cell Lung Cancer

Interventions: Biological: G-CSF
Drug: Cisplatin
Drug: Irinotecan
Drug: Etoposide
Drug: Topotecan

First Posted Date: 2003-04-09

Last Posted Date: 2023-07-05

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 140

Registration Number: NCT00057837

Locations: 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States
🇺🇸
St. Luke's Regional Medical Center, Sioux City, Iowa, United States

and more 75 locations

Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

Phase 2

Terminated

Conditions: Lymphoma

Interventions: Procedure: Extracorporeal Photopheresis
Drug: Pentostatin
Radiation: Total body irradiation (TBI)
Procedure: Allogeneic bone marrow transplantation
Drug: Cyclosporin (CSA)
Drug: Mycophenolate mofetil (MMF)
Drug: Methotrexate (MTX)

First Posted Date: 2003-04-09

Last Posted Date: 2023-06-28

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 6

Registration Number: NCT00057954

Locations: 🇺🇸
St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸
Tufts-NEMC Cancer Center, Boston, Massachusetts, United States
🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

and more 16 locations

Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2003-02-06

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00054561

Locations: 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

and more 86 locations

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-02-06

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 45

Registration Number: NCT00028678

Locations: 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸
West Michigan Cancer Center, Kalamazoo, Michigan, United States
🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States

and more 9 locations

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

Phase 2

Completed

Conditions: Urethral Cancer
Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

Interventions: Drug: gemcitabine hydrochloride
Drug: pemetrexed disodium

First Posted Date: 2003-01-28

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 46

Registration Number: NCT00053209

Locations: 🇺🇸
MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States
🇺🇸
Cancer Center of Kansas - Newton, Newton, Kansas, United States
🇺🇸
Associates in Womens Health, Wichita, Kansas, United States

and more 118 locations

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00049348

Locations: 🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Hematology and Oncology Associates, Chicago, Illinois, United States

and more 134 locations

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

Phase 3

Completed

Conditions: Leukemia
Myelodysplastic Syndromes

Interventions: Biological: filgrastim
Biological: sargramostim
Drug: cytarabine
Drug: daunorubicin hydrochloride
Drug: zosuquidar trihydrochloride
Drug: Placebo

First Posted Date: 2003-01-27

Last Posted Date: 2023-07-05

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 449

Registration Number: NCT00046930

Locations: 🇺🇸
Evanston Northwestern Health Care - Evanston Hospital, Evanston, Illinois, United States
🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸
Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States

and more 88 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy